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Using multivariate regression analysis the interaction between gender 
and positive ERbeta staining was the only signiﬁcant prognostic factor. 
There was no correlation between the ERalfa immunohistochemical 
reaction and any of the clinical variables, including survival. None of 
the 104 patients had tumours positive for Progesterone. 
Conclusion: The presence of ERbeta in a tumour seems to be a posi-
tive prognostic factor for men with non-small cell lung cancer. The 
ﬁndings are in agreement with recent ﬁndings (1) and suggests the area 
of estrogen and lung cancer to be investigated further.
1.  Schwartz AG, Prysak GM, Murphy V, Lonardo F, Pass H, Schwartz J et al. Nuclear 
estrogen receptor beta in lung cancer: expression and survival differences by sex. Clin.
Cancer Res. 2005;11:7280-7.
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Background: Recent molecular studies have provided increased under-
standing of the biology of non-small cell lung cancer (NSCLC) and have 
identiﬁed molecular abnormalities responsible for the modulation of 
tumor growth and the prognosis. Nevertheless, the essential genetic fea-
tures, along with factors for prognosis, have yet to be fully understood. 
This study was undertaken to investigate such immunophenotypes with 
regard to cell cycle regulation and proliferation, apoptosis, and angio-
genesis, and their signiﬁcance to patient outcome.
Design: Two hundred and nineteen NSCLC samples were assembled 
on tissue microarrays, and examined immunohistochemically using 
antibodies against p16, p21, p27, cyclin B1, cyclin E, Ki-67, caspase-
3, survivin, bcl-2, VEGF and endostatin. Clinical information was 
obtained through the computerized retrospective database from the 
tumor registry.
Results: One hundred and sixty-eight patients (76.7%) were male and 
the mean age was 65.8 years (SD 9.9; median 67; age range 19-89). 
Despite previously described prognostic relevance of some of the 11 
investigated molecules, many were found not to be directly associated 
with recurrence or survival. However, p16 and bcl-2 had an impact on 
5-year survival. There was a trend for p16 immunoreactivity to be relat-
ed with a good prognosis (57% vs. 42% in 5-year survival) (p=0.071). 
Bcl-2 expression in tumor tissue strongly correlated with a better out-
come (65% vs. 45% in 5-year survival rate) (p=0.029), and the hazard 
ratio of death for bcl-2 positive patients was 0.42 times of that for bcl-2 
negative patients (p=0.047). A multivariate analysis with Cox propor-
tional hazards model conﬁrmed that the lymph node status (p=0.043) 
and stage (p=0.003) were other independent prognostic factors. 
Conclusion: The present study demonstrates that NSCLCs have het-
erogeneous expression of cell cycle regulatory proteins, apoptotic fac-
tors and angiogenic factors. The expressions of p16 and bcl-2 correlate 
with better survival, suggesting that both proteins provide prognostic 
information independent of TNM stage in NSCLCs.
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Background: Lung cancer is the most common cause of cancer death 
around the world. Diagnosis is critical to decide treatment. However, 
due to technical difﬁculties, it is often difﬁcult to obtain histological 
diagnosis with a clinical workup including bronchoﬁber and CT-guided 
needle biopsy. In such cases, patients undergo resection without a 
histological diagnosis. In some patients, postoperative histological 
examination demonstrates benign diseases. In this study, we identiﬁed 
patients without preoperative histological diagnosis who underwent 
resection and evaluated their histology. We also discuss the inﬂuence of 
CT screening on this issue.
Methods: A retrospective study was performed by reviewing medical 
records between 1997 and 2005. There are 1039 patients who under-
went surgical resection under a diagnosis of lung cancer or suspected 
lung cancer. In 523 patients, histological diagnosis of lung cancer was 
obtained with a routine workup preoperatively. In 516 patients, the 
histological diagnosis was not conﬁrmed preoperatively. We reviewed 
the reasons for the lack of histological diagnosis and classiﬁed patients 
into three groups, 1)bronchoﬁber and/or CT-guided needle biopsy were 
performed but histological diagnosis could not be established; 2)Tumor 
was small and bronchoﬁber and/or CT-guided needle biopsy was not 
performed; and 3)CT imaging indicated highly suspected lung cancer 
and bronchoﬁber and/or CT-guided needle biopsy was skipped. We also 
reviewed postoperative histology. 
Results: Of the 1039 patients who underwent surgical resection under 
a diagnosis of lung cancer or suspected lung cancer between 1997 
and 2005, preoperative histological diagnosis was not obtained in 516 
patients (46.2%). In our area, CT screening was initiated in 1998. The 
proportion of undiagnosed cases was approximately 30 % before 1998 
and increased to approximately 55 % after 1999. The increase seemed 
to be related to the initiation of CT screening. In 108 patients, broncho-
ﬁber and /or CT-guided needle biopsy was performed but histological 
diagnosis could not be obtained. In 270 patients, the tumor was consid-
ered too small for bronchoﬁber or CT-guided needle biopsy and these 
modalities were not performed. In 138 patients, CT imaging highly 
suspected lung cancer and resection was performed without histologi-
cal conﬁrmation. Postoperative histological examination demonstrated 
primary lung cancer in 422 patients (81.8%), metastatic lung cancer in 
25 (4.8%) and benign disease in 69 (13.4%). 
Comment: We reviewed 516 patients who underwent resection 
without histological diagnosis. After the initiation of CT screening, the 
proportion of cases that were not diagnosed preoperatively increased 
to approximately 55 %. Histological examination demonstrated benign 
diseases in 69(13.4%). Recently small lung tumor has been detected 
more frequently, especially since the initiation of CT screening. Some 
patients undergo resection without histological conﬁrmation. Surgical 
indications for undiagnosed cases should be considered carefully. 
